Literature DB >> 269099

Studies of bone and soft-tissue tumours induced in rats with radioactive cerium chloride.

B Klein, S Pals, R Masse, J Lafuma, M Morin, N Binart, J R Jasmin, C Jasmin.   

Abstract

A colloidal suspension of radioactive cerium chloride was inoculated into the hind legs of Sprague Dawley rats. Bone and soft-tissue tumours were induced at the site of inoculation in 77% of the animals. All bone tumours were osteogenic osteosarcomas. Soft tissue tumours were mostly malignant and were of various histological types, predominantly fibrosarcomas, haemangiopericytomas, angiosarcomas and rhabdomyosarcomas. A kinetic study showed that the doubling time (DT) of tumours was closely correlated with the anatomical site of tumour development: bone tumours had a DT of 17.4 +/- 4.3 days and malignant tumours which developed in soft tissues had a DT ranging from 7.4 to 8.4 days with the exception of two haemangiosarcomas which had a long DT of 17 +/- 0.6 days. Pulmonary metastases were frequent for osteosarcomas and tumours of vascular origin. This model of induction of bone and soft-tissue tumours in rats by injection of a colloidal suspension of radioactive cerium chloride offers the possibility of more comprehensive physiopathological and kinetic studies of these tumours and may constitute a good model for their human counterparts.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 269099     DOI: 10.1002/ijc.2910200118

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.

Authors:  Gatien Moriceau; Benjamin Ory; Laura Mitrofan; Chiara Riganti; Frédéric Blanchard; Régis Brion; Céline Charrier; Séverine Battaglia; Paul Pilet; Marc G Denis; Leonard D Shultz; Jukka Mönkkönen; Françoise Rédini; Dominique Heymann
Journal:  Cancer Res       Date:  2010-10-22       Impact factor: 12.701

2.  An experimental transplantable osteosarcoma with spontaneous pulmonary metastasis in hamsters.

Authors:  M Sekiguchi; T Satomura; M Saëgusa; H Takeuchi; K Asanuma; T Shimoda
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

3.  Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.

Authors:  S Théoleyre; K Mori; B Cherrier; N Passuti; F Gouin; F Rédini; D Heymann
Journal:  BMC Cancer       Date:  2005-09-27       Impact factor: 4.430

4.  Bone tumours induced in rats with radioactive cerium.

Authors:  H G Delbrück; M Allouche; C Jasmin; M Morin; F Deml; L Anghileri; R Masse; J Lafuma
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

5.  Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells.

Authors:  B Ory; G Moriceau; V Trichet; F Blanchard; M Berreur; F Rédini; M Rogers; D Heymann
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

6.  Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models.

Authors:  Bérengère Gobin; Gatien Moriceau; Benjamin Ory; Céline Charrier; Régis Brion; Frederic Blanchard; Françoise Redini; Dominique Heymann
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.